Lexicon Pharmaceuticals (LXRX) Non-Current Deferred Tax Liability (2010 - 2019)

Lexicon Pharmaceuticals (LXRX) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $6.0 million in Q2 2019.

• On a quarterly basis, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $6.0 million in Q2 2019; TTM through Jun 2019 was $6.0 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $6.0 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability for Q2 2019 stood at $6.0 million, roughly flat from $6.0 million in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for LXRX reached as high as $18.7 million in Q1 2015 and fell as low as $6.0 million in Q4 2017.
• Historically, Non-Current Deferred Tax Liability has averaged $12.3 million across 5 years, with a median of $10.0 million in 2017.
• Across the five-year window, Non-Current Deferred Tax Liability changed 0.0% in 2015 and tumbled 67.8% in 2017, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $18.7 million in 2015, then changed by 0.0% to $18.7 million in 2016, then tumbled by 67.8% to $6.0 million in 2017, then changed by 0.0% to $6.0 million in 2018, then changed by 0.0% to $6.0 million in 2019.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $6.0 million in Q2 2019, $6.0 million in Q1 2019, and $6.0 million in Q4 2018.